We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welcome to Wall Street gamesmanship, Anthropic ANT! After an historically successful IPO Thursday, whereby the already higher-than-expected initial trading price of $83 per share shot up +17% to $97.17 per share by the closing bell. It was a record-setting $81.3 billion IPO for the first publicly traded pure-play frontier AI firm. This morning, the share price has already unwound -12% of those gains. Plenty of people felt it was a good time to book profits.
This has led to another ugly sell-off on the tech-heavy Nasdaq this morning: -2.06%, or -548 points. The Dow, which shed -1100 points yesterday, is off another -223 (-0.45%) at this hour. The S&P 500 is -81 points and the small-cap Russell 2000 is -13 points. It’s been just a bloody month of November trading, especially since Veteran’s Day (11/11).
We’re even closing in on having lost our gains year to date. Normally, Q4 is a strong quarter for the stock market, where a “Santa Rally” comes in like icing on a cake. These days, we may be relying on something of a Santa Rally just to stay positive for 2026.
Then again, this would show the pattern of the past decade or so remaining intact: three straight years of double-digit market gains (S&P 500) followed by one year finishing in the red. The last time we had a down-year was particularly bad, 2022, which fell -19%. So perhaps this is the natural ebb and flow of the market. Then again, there are always possibilities for a late-year rally to spur us out of this downward slope.
What to Expect from the Stock Market Today
Later this morning, the final print for the University of Michigan Consumer Sentiment survey for November comes out. In the preliminary look, we saw things improve slightly from 48 the previous month to 51 this month. Forecasts are for a further bump to 51.5.
We haven’t been in the normal 80-100 range for a sustained period since pre-Covid — that’s a long time for the American consumer to carry around insecurities. As a matter of fact, we continue to wallow at all-time lows on the index, likely due to a murky outlook regarding AI, the Iran war and a years-long deep freeze in the housing market.
Also, we will hear speeches today from Fed Governors Christopher Waller and Lisa Cook, as well as Richmond, VA President Tom Barkin. Earlier this week, we were hearing some rumbles that the Fed might be interested in raising interest rates at its December 8-9 meeting by 50 basis points (bps), but New York Fed President John Williams seems to have effectively doused that notion for now.
We cover more than 1,000 of the most widely followed stocks in our Equity Research Reports. Each report features independent research from our analysts and provides in-depth analysis on a company, its fundamentals and its growth prospects. Quickly access reports for New Upgrades and New Downgrades.
You can also find a report on the ticker of your choice, or access all of the stock reports covered by Zacks analysts.
AI power expansion, broader automotive content, differentiated product platforms, factory efficiencies and disciplined cash generation support sustained earnings growth potential.
Disciplined underwriting, fee earnings, acquisition scale, productive capital deployment, cash generation, investment income and shareholder distributions support long-term capital compounding.
Brand momentum, healthier full-price selling, international expansion, PINK relevance, store modernization and liquidity support a more durable growth trajectory overall.
VITAS growth normalization, favorable hospice demand, Roto-Rooter initiatives and disciplined capital deployment support Chemed’s long-term earnings, cash flow and expansion.
Regulatory uncertainty, financing demands, market-sensitive pipeline activity, competition and aging infrastructure can offset benefits from the company’s regulated growth strategy.
Escalating expenses in the near term along with higher legal costs owing to any litigation issues will likely limit bottom-line growth. Deteriorating credit quality is a key concern for Deutsche Bank.
Freight and tariff uncertainty, inventory-clearing requirements, nonrecurring profit benefits and continued expense growth could constrain URBN’s margin expansion.
Elevated operating expenses remain a major headwind for EZCORP. Further, merchandise sales dependence and gold price volatility may pressure earnings growth.
Innovative Medicines/Pharma segment is the primary growth engine , driven by key products like Darzalex, Tremfya and Erleada and continued uptake of newer drugs, Spravato, Carvykti and Tecvayli.
Diversified brands, consistent execution, restaurant expansion, menu innovation and disciplined capital allocation support competitive positioning, earnings durability and shareholder returns.
Digital growth, retail media, private labels, cost discipline and balance sheet flexibility support Kroger’s long-term earnings and durable shareholder returns.
Portfolio simplification, innovation, share gains, logistics productivity, TRIXIE expansion and ample liquidity support a more durable long-term earnings profile.
Global malocclusion opportunity, portfolio expansion, international adoption, digital workflows, DSO relationships and financial flexibility support Align Technology’s long-term growth prospects.
Traffic, digital convenience, merchandising upgrades, higher-margin revenue streams and disciplined investment support Target’s path toward sustainable profitable growth over time.